Refine and validate imaging biomarkers analytically for early detection of breast, lung, and other cancers for effective clinical applications and use and to construct imaging data and specimen resources for EDRN collaborations and sharing (Jae Lee, PhD, Lead).

•    Clinical validation of Lung Cancer LDCT radiomics features to improve current USPSTF screening by developing, refining, and validating integrated image biomarker models under an EDRN-defined phase IV study.  [metaslider id=102]

•   Clinical validation of breast cancer DBT data: develop and validate DBT image biomarkers for early detection of breast cancer based on EDRN-defined case-control (phase II) and/or prospective-retrospective (phase III) studies.  [metaslider id=106]